Prestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce Conference
Rhea-AI Summary
Prestige Consumer Healthcare (NYSE:PBH) will join the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference via a virtual fireside chat on Monday, June 8, 2026 at 9:45 a.m. ET.
A live webcast and replay will be available on the company’s investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – PBH
In the Jun 5 session, PBH gained 3.83%, reflecting a moderate positive market reaction. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 13 | Earnings and acquisition | Positive | -11.3% | Fiscal 2026 results and LaCorium Health acquisition with forward guidance. |
| Apr 30 | Earnings date notice | Neutral | +0.5% | Announcement of fiscal 2026 Q4 and year-end earnings release timing. |
| Mar 20 | Acquisition agreement | Positive | +1.6% | Agreement to acquire Breathe Right and other OTC brands with accretive profile. |
| Feb 05 | Earnings update | Positive | -2.2% | Q3 fiscal 2026 results and narrowed full-year guidance with cash flow focus. |
| Jan 12 | Earnings date and conference | Neutral | +1.8% | Third-quarter earnings date and participation in ICR Conference announced. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows PBH often diverging from seemingly positive or neutral news, with several earnings and acquisition updates followed by limited or negative price reactions.
Over the last six months, PBH has reported multiple earnings updates and two notable acquisitions, including Breathe Right® and LaCorium Health, alongside fiscal 2026 results and guidance. Price reactions to earnings and acquisition announcements have been mixed, with some positive strategic news followed by negative moves, such as the May 13 fiscal 2026 results and LaCorium deal. Today’s simple conference-participation notice fits within a pattern where informational or strategic updates do not consistently translate into supportive near-term trading.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TARRYTOWN, N.Y., June 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference virtually on Monday, June 8, 2026 at 9:45 a.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:
https://ir.prestigebrands.com/events-presentations/events
For those unable to participate during the live webcast, a replay option will be available on the Company’s website following the event.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact Phil Terpolilli, CFA, 914-524-6819 irinquiries@prestigebrands.com